ClinicalTrials.gg
CompletedNCT06958510Updated Dec 31, 2025

Modified Anatomical Mesh In The Management Of Orbito-Zygomatico-Maxillary Complex Fractures

An interventional study of 3D-Modified Anatomical-Mesh. and conventional orbital rim miniplates and orbital mesh configuration in Orbital Fractures and Zygomatic Fractures, sponsored by Alexandria University. Completed at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-12-31.

Sponsored by Alexandria University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Oct 2024, registered Apr 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 12 studies in Orbital Fractures with a site in Egypt — 3 open to participants now, 3 under way, none of them phase 3. Orbital Fractures · Egypt.

Enrollment
6th of 12
24 · median 22
Started
2024
with 1 other
No phase
11 of 12
3 open now
Registered
8th of 12
by date
Lead sponsor
2 of 12
Alexandria University

Among the 12 studies in Orbital Fractures with a site in Egypt, this one is the 6th largest by enrollment, is one of 2 that started in 2024, is one of 11 with no phase, and was the 8th registered.

Orbital Fractures

29 studies on the registry are indexed under Orbital Fractures; 6 are open to participants now.

Browse Orbital Fractures studies →

Open to participants now

3 of the 12 studies in Orbital Fractures with a site in Egypt are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 3 Orbital Fractures studies recruiting now, none set no upper age limit and 3 stop at 75 or younger; none take children under 18; 2 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Orbital Fractures with a site in Egypt, or all of them as a file.
02

Study summary

Orbito-Zygomaticomaxillary-complex fractures is a form of a complex orbital floor fracture, with affection of the inferior orbital rim and the orbital walls. According to published research, between 67 - 84 % of periorbital bone fractures are orbital floor fractures.

Evaluation of 3D-Modified Anatomic Mesh in the management of OZM- complex fractures with orbital floor defect, and compare it with the conventional fixation configuration.

Read the detailed description

Patients suffering from OZM- complex fractures was treated using 3D-Modified Anatomical Mesh for orbital floor reconstruction and orbital rim fixation. Patients was randomly allocated into study and control groups, where it is managed with the conventional 2.0-miniplate and stock mesh. A standardized surgical protocol was followed in both groups. Patients was clinically evaluated for pain, wound healing, nerve sensation, ocular motility and diplopia, and tarsal plate morphology. Moreover, radiographic survey was performed post operatively to assess the proper positioning of the implant, to confirm proper fracture reduction, and radiographic enophthalmos analysis

03

Conditions studied

  • Orbital Fractures
  • Zygomatic Fractures

Browse trials for

Keywords

  • anatomical mesh
  • 3D-mesh
  • orbital mesh
  • orbital fracture
  • zygomatic fracture
  • reconstruction
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients suffering from Orbito-Zygomaticomaxillary complex fractures with fracture in the orbital floor and orbital floor defect(16).
  2. Fractures that are indicated for open reduction and internal fixation.
  3. Patients suffering from ocular complications:

    1. Monocular diplopia.
    2. Enophthalmos above 2 mm.
    3. Restricted ocular motility.
  4. Patients with orbital wall defects with orbital soft tissue herniation into the maxillary sinus.
  5. Adult patient either male or female that agrees to present for follow-up visits for an adequate postoperative period.

Exclusion criteria

Exclusion Criteria:

  1. Patients with isolated orbital floor defects and blowout fractures.
  2. Patients with isolated zygomatico-maxillary complex fracture with no orbital floor/ walls defects.
  3. Patients with bilateral orbital defects.
  4. Patients with Infected wounds in periorbital region.
  5. Medically compromised patients rendering them inoperable.
  6. Patients with ruptured globe or blindness.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
24 participants (actual)

Study arms

  • Active comparator
    Patients with Orbito-Zygomaticomaxillary Complex fracture managed with 3D-Modified Anatomical-Mesh

    Patients with Orbito-Zygomaticomaxillary Complex fracture managed with 3D-Modified Anatomical-Mesh

    Device: 3D-Modified Anatomical-Mesh.

  • Experimental
    Patients with Orbito-Zygomaticomaxillary Complex fracture managed with conventional orbital rim mini

    Patients with Orbito-Zygomaticomaxillary Complex fracture managed with conventional orbital rim mini

    Device: conventional orbital rim miniplates and orbital mesh configuration

Interventions

  • Device3D-Modified Anatomical-Mesh.

    3D-Modified Anatomical-Mesh.

  • Deviceconventional orbital rim miniplates and orbital mesh configuration

    conventional orbital rim miniplates and orbital mesh configuration

06

What researchers measure

Primary outcomes

  1. Radiographic assessment of the management of the Orbito-Zygomaticomaxillary Complex fracture

    Radiographic assessment of the management of the Orbito-Zygomaticomaxillary Complex fracture

    Time frame: 1 week

Secondary outcomes

  1. Periorbital ecchymosis

    Postoperative periorbital ecchymosis will be evaluated on a 3-points scale (0-3). The scoring system divides ecchymosis into upper and lower eyelids, and furthermore into thirds for each eyelid.

    Time frame: 6 weeks

07

Study locations

1 site
  • Faculty of Dentistry, Alexandria University
    Alexandria, Alexandria Governorate 21523, Egypt
08

References and documents

Individual participant data

Plan to share: Yes — all data will be de-identified to protect the participant data. patients signed an informed consent for the use of their medical records and data for study

Supporting information: Statistical analysis plan

Access criteria: to any one who required them after deidentification

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Oct 2024 to primary completion in Mar 2025, 5 months.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 16, 2025
First posted
May 6, 2025
StartActual
Oct 1, 2024
Primary completionActual
Mar 1, 2025
CompletionActual
Jun 15, 2025
Last update
Dec 31, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 31, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06958510
Responsible party
Sponsor
First posted
May 6, 2025
Start date
Oct 1, 2024
Primary completion
Mar 1, 2025
Completion
Jun 15, 2025
Last update
Dec 31, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion